Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients Clinical research trials and A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients. A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients clinical trial. Test subjects typically receive the most expert healthcare available for their A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.

Home > "A" Clinical Trials Conditions > A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients

A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients



A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients

For Condition: HIV Infections
Status: Completed
Sponsor(s): Pharmacia and Upjohn ,
Synopsis: The purpose of this study is to compare the safety and effectiveness of giving HIV-infected patients delavirdine (DLV) plus zidovudine (ZDV) plus 2 doses of indinavir (IDV) or ZDV plus IDV plus lamivudine (3TC). This study also examines how the body processes DLV when it is given in combination with other drugs.
Details: In this multicenter, open-label study, 45 HIV-1-positive patients receive either combination drug therapy with delavirdine (DLV), zidovudine (ZDV), and indinavir (IDV) or combination drug therapy with ZDV, lamivudine (3TC), and IDV. NOTE: Patients are treated for 24 weeks and may opt to continue on study for 24 additional weeks, if HIV-1 RNA is less than 5,000 copies/ml or at the investigator's discretion.
Eligibility:
Study Type:  Interventional, Treatment, Safety Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Patients must have: - HIV-1 positive. - CD4 count above 50. - HIV-1 RNA greater than 20,000. Prior Medication: Allowed: Less than 1 month prior treatment with zidovudine. Exclusion Criteria Prior Medication: Excluded: - Prior 3TC, protease inhibitors, or non-nucleoside reverse transcriptase inhibitors. - Prior ZDV of greater than 1 month total duration. Prior Treatment: Excluded: - Lamivudine. - Protease inhibitors. - Non-nucleoside reverse transcriptase inhibitors.
Total Enrollment: 45

Location and Contact Information:

Pharmacia & Upjohn
Peapack,  New Jersey,  07977
United States
 


Additional Information:
Study ID Numbers:  228C;  0063
Study Start Date: 
Record last reviewed: January 1999
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002400

Other Hiv Infections Studies:
1. A Comparison of Two Anti-HIV Treatment Plans

2. ALVAC-HIV vCP1452 Alone and Combined with MN rgp120

3. The Safety and Effects of 1592U89 Used Alone or in Combination with Other Anti-HIV Drugs in HIV-Infected Infants and Children

4. A Study of HIV Levels During Pregnancy and After Childbirth

5. Growth Hormone to Increase Immune Function in People with HIV

Related Studies:

Other HIV Infections Clinical Trials
Other New Jersey Clinical Trials
Other Peapack Clinical Trials

A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients
Modify your Search

  Other HIV Infections Clinical Trials
  Other New Jersey Clinical Trials
  Other Peapack Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103